Overview Financials News + Filings Key Docs Charts Ownership
|
|
Intellipharmaceutics International Inc. (IPCI)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions of CAD, except per share items | May-31-23 | Feb-28-23 | Aug-31-22 | May-31-22 | Feb-28-22 | Nov-30-21 | Aug-31-21 | May-31-21 |
| | 6-K | 6-K | 6-K | 6-K | 6-K | S-1/A | 6-K | 6-K |
| Net income | -0.1 | -0.4 | 0.0 | -0.8 | -0.9 | -2.0 | 0.0 | -1.0 |
| Depreciation and amortization [+] | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Stock-based compensation | | | | | | | | 0.0 |
| Change in working capital [+] | 0.1 | 0.5 | 0.0 | 0.9 | 0.3 | 2.0 | -0.4 | 0.1 |
| Accounts receivable | -0.1 | | | 0.0 | | 1.1 | | -0.1 |
| Inventories | | | | | | 0.0 | 0.0 | |
| Other current assets | 0.0 | 0.0 | 0.1 | 0.0 | -0.2 | | -0.1 | 0.0 |
| Other | 0.2 | 0.6 | -0.1 | 0.9 | 0.5 | 0.8 | -0.4 | 0.3 |
| Other operating activities | 0.0 | -0.2 | -0.3 | -0.5 | 0.0 | -0.4 | -1.0 | 0.0 |
| Cash from operations | 0.1 | 0.0 | -0.3 | -0.3 | -0.6 | -0.3 | -1.4 | -0.8 |
| |
| Capital expenditures [+] | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Sales of property and equipment | | | | 0.5 | | | | |
| Cash from investing | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Issuance of common stock, net | | | | | | | | 3.1 |
| Other cash from financing | | | | | | | | 0.0 |
| Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.0 |
| |
| Free cash flow | 0.1 | 0.0 | -0.3 | -0.3 | -0.6 | -0.3 | -1.4 | -0.8 |
| Per share (diluted) | | $0.00 | | | ($0.02) | ($0.01) | ($0.04) | |
| |
|